Oncogenic BRAF: A new potential therapeutic target.
- Published in:
- Oncology (08909091), 2011, v. 25, n. 2, p. 112
- Publication type:
- Article
Works matching DE "GENENTECH Inc."
Results: 237
1
2
Announcements.
- Published in:
- Oncology (08909091), 2009, v. 23, n. 9, p. 743
- Publication type:
- Article
3
First-Line Maintenance With Erlotinib/Bevacizumab Improves Progression-Free Survival in Advanced Lung Cancer.
- Published in:
- Oncology (08909091), 2009, v. 23, n. 2, p. 182
- Publication type:
- Article
4
Announcements.
- Published in:
- Oncology (08909091), 2006, v. 20, n. 14, p. 1877
- Publication type:
- Article
5
Trastuzumab and Beyond: New Possibilities for the Treatment of HER2-Positive Breast Cancer.
- Published in:
- Oncology (08909091), 2006, v. 20, n. 14, p. 1763
- By:
- Publication type:
- Article
6
Bevacizumab/Chemo Combination Approved for Treating Metastatic Colorectal Cancer.
- Published in:
- Oncology (08909091), 2006, v. 20, n. 8, p. 942
- Publication type:
- Article
7
Fourth Phase III Study Shows Trastuzumab/Chemotherapy Improved Disease-Free Survival in Breast Cancer Patients.
- Published in:
- Oncology (08909091), 2005, v. 19, n. 11, p. 1
- Publication type:
- Article
8
Meet Tanuki, a 10,000-core Supercomputer in the Cloud.
- Published in:
- Bio-IT World, 2011, v. 10, n. 3, p. 11
- By:
- Publication type:
- Article
9
A Bioinformatics Chief and a Gentleman.
- Published in:
- 2010
- By:
- Publication type:
- Interview
10
Trial Portal Tightens Bond with Investigative Sites.
- Published in:
- Bio-IT World, 2009, v. 8, n. 4, p. 24
- By:
- Publication type:
- Article
11
2009 Winners and Honorable Mentions.
- Published in:
- Bio-IT World, 2009, v. 8, n. 4, p. 21
- Publication type:
- Article
12
Engines of Discovery.
- Published in:
- Bio-IT World, 2004, v. 3, n. 11, p. 12
- By:
- Publication type:
- Article
13
Finding the Perfect Fit.
- Published in:
- Bio-IT World, 2004, v. 3, n. 4, p. 36
- By:
- Publication type:
- Article
14
STRATEGIC INSIGHTS.
- Published in:
- Bio-IT World, 2003, v. 2, n. 12, p. 44
- By:
- Publication type:
- Article
15
Sally Smith Hughes, Genentech: The Beginnings of Biotech.
- Published in:
- 2013
- By:
- Publication type:
- Book Review
16
Ranibizumab: A Viewpoint by Steven D. Schwartz.
- Published in:
- Drugs, 2007, v. 67, n. 8, p. 1207
- Publication type:
- Article
17
Response of Diabetic Papillopathy to Intravitreal Bevacizumab.
- Published in:
- 2011
- By:
- Publication type:
- Case Study
18
GH Treatment.
- Published in:
- Current Medical Literature: Growth, Growth Hormone, & Metabolism, 2009, v. 2, n. 3, p. 89
- Publication type:
- Article
19
Straight talk with...Jamie Heywood.
- Published in:
- Nature Medicine, 2014, v. 20, n. 5, p. 457, doi. 10.1038/nm0514-457
- Publication type:
- Article
20
Drugs in traffic: the road to approval.
- Published in:
- Nature Medicine, 2011, v. 17, n. 12, p. 1542, doi. 10.1038/nm1211-1542
- Publication type:
- Article
21
Difficult decisions.
- Published in:
- 2011
- Publication type:
- Editorial
22
Companies race to develop first Hedgehog inhibitor cancer drug.
- Published in:
- Nature Medicine, 2011, v. 17, n. 5, p. 523, doi. 10.1038/nm0511-523
- By:
- Publication type:
- Article
23
Fearful of Avastin's fate, Genentech asks for unusual hearing.
- Published in:
- Nature Medicine, 2011, v. 17, n. 3, p. 233, doi. 10.1038/nm0311-233
- By:
- Publication type:
- Article
24
Battle over eye medicine gives drugmaker a dose of reality.
- Published in:
- Nature Medicine, 2008, v. 14, n. 2, p. 108, doi. 10.1038/nm0208-108
- By:
- Publication type:
- Article
25
Supreme Court Says You Can License and Sue.
- Published in:
- Research Technology Management, 2007, v. 50, n. 2, p. 9
- By:
- Publication type:
- Article
26
NEWSBRIEFS.
- Published in:
- Research Technology Management, 2005, v. 48, n. 5, p. 9
- Publication type:
- Article
27
Genentech Human Resources Journey of Discovery.
- Published in:
- Workforce Solutions Review, 2014, v. 5, n. 1, p. 18
- By:
- Publication type:
- Article
28
Genentech: The Beginnings of Biotech.
- Published in:
- 2012
- By:
- Publication type:
- Book Review
29
Estimating Hypothetically Negotiated Royalty Rates after Medlmmune, Inc. v. Genentech, Inc., et al.
- Published in:
- Journal of Legal Economics, 2008, v. 14, n. 3, p. 43
- By:
- Publication type:
- Article
30
Genentech.
- Published in:
- 2012
- By:
- Publication type:
- Book Review
31
News in brief.
- Published in:
- Chemistry & Industry, 2009, n. 5, p. 7
- Publication type:
- Article
32
Genentech rejects Roche.
- Published in:
- Chemistry & Industry, 2008, n. 16, p. 5
- By:
- Publication type:
- Article
33
Roche sets sights on biotech giant.
- Published in:
- Chemistry & Industry, 2008, n. 15, p. 5
- By:
- Publication type:
- Article
34
Pharma briefs.
- Published in:
- Chemistry & Industry, 2007, n. 2, p. 9
- Publication type:
- Article
35
US allows patent dilution.
- Published in:
- Chemistry & Industry, 2007, n. 2, p. 9
- By:
- Publication type:
- Article
36
Lonza expands into biopharm.
- Published in:
- Chemistry & Industry, 2006, n. 22, p. 10
- By:
- Publication type:
- Article
37
News in brief.
- Published in:
- Chemistry & Industry, 2006, n. 13, p. 6
- Publication type:
- Article
38
Cell culture grows capacity.
- Published in:
- Chemistry & Industry, 2005, n. 20, p. 21
- Publication type:
- Article
39
Genentech sees shares surge.
- Published in:
- Chemistry & Industry, 2005, n. 14, p. 5
- Publication type:
- Article
40
Avastin check for Genentech.
- Published in:
- Chemistry & Industry, 2004, n. 17, p. 4
- By:
- Publication type:
- Article
41
Genentech exceeds sales expectations.
- Published in:
- Chemistry & Industry, 2004, n. 8, p. 7
- By:
- Publication type:
- Article
42
Avastin Hearing Leads to More Uncertainty Over Drug’s Future.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2011, v. 103, n. 15, p. 1148, doi. 10.1093/jnci/djr293
- By:
- Publication type:
- Article
43
Alteplase for the Management of Occluded Central Venous Access Devices: Safety Considerations.
- Published in:
- Clinical Journal of Oncology Nursing, 2008, v. 12, n. 1, p. 155, doi. 10.1188/08.CJON.155-157
- By:
- Publication type:
- Article
44
Bevacizumab (Avastin®).
- Published in:
- Clinical Journal of Oncology Nursing, 2004, v. 8, n. 6, p. 666
- By:
- Publication type:
- Article
45
Alteplase (Cathflo Activase ).
- Published in:
- Clinical Journal of Oncology Nursing, 2004, v. 8, n. 4, p. 417, doi. 10.1188/04.CJON.417-418
- By:
- Publication type:
- Article
46
FDA Approves New Agent for Occluded Central Venous Access Devices.
- Published in:
- Clinical Journal of Oncology Nursing, 2002, v. 6, n. 2, p. 72
- Publication type:
- Article
47
ONS Foundation to Fund Outcomes Research and Symptom Management Grants.
- Published in:
- ONS News, 2001, v. 16, n. 1, p. 6
- Publication type:
- Article
48
MARKETPLACE: Drug & therapeutics update.
- Published in:
- Oncology Exchange, 2012, v. 11, n. 3, p. 47
- Publication type:
- Article
49
Genentech: The Beginnings of Biotech.
- Published in:
- 2014
- By:
- Publication type:
- Book Review
50
Industry Pipeline.
- Published in:
- Ocular Surgery News, 2010, v. 28, n. 4, p. 34
- Publication type:
- Article